Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Embryonic stem cells overexpressing Pitx2c engraft in infarcted myocardium and improve cardiac function.

Guddati AK, Otero JJ, Kessler E, Aistrup G, Wasserstrom JA, Han X, Lomasney JW, Kessler JA.

Int Heart J. 2009 Nov;50(6):783-799.

2.

Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts.

Christoforou N, Oskouei BN, Esteso P, Hill CM, Zimmet JM, Bian W, Bursac N, Leong KW, Hare JM, Gearhart JD.

PLoS One. 2010 Jul 12;5(7):e11536. doi: 10.1371/journal.pone.0011536.

3.

MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.

Glass C, Singla DK.

Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2038-49. doi: 10.1152/ajpheart.00271.2011. Epub 2011 Aug 19.

4.

Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.

Glass C, Singla DK.

Cell Transplant. 2012;21(9):1931-44. doi: 10.3727/096368911X627561. Epub 2012 Mar 22.

PMID:
22449760
5.

The infarcted cardiac microenvironment cannot selectively promote embryonic stem cell differentiation into cardiomyocytes.

Chen YR, Li Y, Chen L, Yang XC, Su PX, Cai J.

Cardiovasc Pathol. 2011 Mar-Apr;20(2):77-83. doi: 10.1016/j.carpath.2009.12.003. Epub 2010 Feb 8.

PMID:
20117024
6.

Human embryonic stem cell transplantation to repair the infarcted myocardium.

Leor J, Gerecht S, Cohen S, Miller L, Holbova R, Ziskind A, Shachar M, Feinberg MS, Guetta E, Itskovitz-Eldor J.

Heart. 2007 Oct;93(10):1278-84. Epub 2007 Jun 12.

7.

Characterization of rat very small embryonic-like stem cells and cardiac repair after cell transplantation for myocardial infarction.

Wu JH, Wang HJ, Tan YZ, Li ZH.

Stem Cells Dev. 2012 May 20;21(8):1367-79. doi: 10.1089/scd.2011.0280. Epub 2011 Oct 27.

PMID:
22032240
8.

Pitx2c modulates cardiac-specific transcription factors networks in differentiating cardiomyocytes from murine embryonic stem cells.

Lozano-Velasco E, Chinchilla A, Martínez-Fernández S, Hernández-Torres F, Navarro F, Lyons GE, Franco D, Aránega AE.

Cells Tissues Organs. 2011;194(5):349-62. doi: 10.1159/000323533. Epub 2011 Mar 9.

PMID:
21389672
9.

Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells.

Nelson TJ, Ge ZD, Van Orman J, Barron M, Rudy-Reil D, Hacker TA, Misra R, Duncan SA, Auchampach JA, Lough JW.

Anat Rec A Discov Mol Cell Evol Biol. 2006 Nov;288(11):1216-24.

10.

The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.

Moon SH, Kang SW, Park SJ, Bae D, Kim SJ, Lee HA, Kim KS, Hong KS, Kim JS, Do JT, Byun KH, Chung HM.

Biomaterials. 2013 May;34(16):4013-26. doi: 10.1016/j.biomaterials.2013.02.022. Epub 2013 Mar 5.

PMID:
23465823
11.

Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.

Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L.

J Am Coll Cardiol. 2007 Nov 6;50(19):1884-93. Epub 2007 Oct 23.

12.
13.

Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts.

Cai J, Yi FF, Yang XC, Lin GS, Jiang H, Wang T, Xia Z.

Cytotherapy. 2007;9(3):283-91.

PMID:
17464760
14.

Functional properties of human embryonic stem cell-derived cardiomyocytes.

Zeevi-Levin N, Itskovitz-Eldor J, Binah O.

Crit Rev Eukaryot Gene Expr. 2010;20(1):51-9. Review.

PMID:
20528737
15.

Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression.

He Q, Trindade PT, Stumm M, Li J, Zammaretti P, Bettiol E, Dubois-Dauphin M, Herrmann F, Kalangos A, Morel D, Jaconi ME.

J Cell Mol Med. 2009 Jan;13(1):188-201. doi: 10.1111/j.1582-4934.2008.00323.x. Epub 2008 Mar 28.

16.

Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells.

Min JY, Yang Y, Sullivan MF, Ke Q, Converso KL, Chen Y, Morgan JP, Xiao YF.

J Thorac Cardiovasc Surg. 2003 Feb;125(2):361-9.

17.

Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium.

Cho SW, Gwak SJ, Kim IK, Cho MC, Hwang KK, Kwon JS, Choi CY, Yoo KJ, Kim BS.

Biochem Biophys Res Commun. 2006 Feb 10;340(2):573-82. Epub 2005 Dec 19.

PMID:
16376856
18.

Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice.

Ke Q, Yang Y, Rana JS, Chen Y, Morgan JP, Xiao YF.

Sheng Li Xue Bao. 2005 Dec 25;57(6):673-81.

19.

Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.

Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, Sasse P, Rubenchik O, Fries JW, Wenzel D, Geisen C, Xia Y, Lu Z, Duan Y, Kettenhofen R, Jovinge S, Bloch W, Bohlen H, Welz A, Hescheler J, Jacobsen SE, Fleischmann BK.

J Exp Med. 2006 Oct 2;203(10):2315-27. Epub 2006 Sep 5.

20.

Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.

Riegler J, Tiburcy M, Ebert A, Tzatzalos E, Raaz U, Abilez OJ, Shen Q, Kooreman NG, Neofytou E, Chen VC, Wang M, Meyer T, Tsao PS, Connolly AJ, Couture LA, Gold JD, Zimmermann WH, Wu JC.

Circ Res. 2015 Sep 25;117(8):720-30. doi: 10.1161/CIRCRESAHA.115.306985. Epub 2015 Aug 19.

Supplemental Content

Support Center